Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Change in Working Capital

-$3.97M

TTM · Period ending: · USD

LCTX logo

LCTX Change in Working Capital

Latest reported-$3.97M
LCTX TTM Change in Working Capital ($200.00K → -$3.97M)
High-resolution chart · PNG

LCTX change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
59,098
5,676
-251,127
-371,517
1,049,079
183,609
440,369
300,000
-1,200,000
-1,000,000
-900,000
2,000,000
1,800,000
1,600,000
1,200,000
-2,500,000
-2,300,000
-2,100,000
2,100,000
2,100,000
5,800,000
6,000,000
2,100,000
2,700,000
-1,100,000
-1,200,000
200,000
300,000
300,000
5,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.